ARKgen BioScions
PrivateLast Round
Series A
Jul 13, 2026
Total Funding Raised
$9.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
ARKgen BioScions is a biotechnology company that develops multispecific antibody-based immuno-oncology therapeutics using its proprietary AMB platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ARKgen BioScions Comparables
Compare ARKgen BioScions with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| De Novo Biotherapeutics | 81% | |
| Invenra | 81% | |
| Numab Therapeutics | 78% | |
ARKgen BioScions Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 13, 2026 | ||||
| Pre Seed | Dec 1, 2023 |
ARKgen BioScions Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Woori Venture Partners Co., Ltd. | Series A |
| IBK Venture Investment | Series A |
| ScaleUp Partners | Series A |
| IMM Investment | Series A |
| Korea Credit Guarantee Fund | Series A |
| Industrial Bank of Korea | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 13, 2026
$7M round with participation from IBK Venture Investment and IMM Investment.
- Dec 1, 2023
$3M raised in Pre Seed round.
ARKgen BioScions Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ARKgen BioScions's valuation, stock price, and market status.